Back to Results
First PageMeta Content
Immunology / Glycoproteins / Antibody / Monoclonal antibodies / Monoclonal antibody therapy / Polyclonal antibodies / Complementarity determining region / Antigen / Immunoglobulin M / Immune system / Biology / Anatomy


The "Anti" - Written Description Requirement? Antibodies, Example 16, The Guidelines, and Noelle v. Lederman James J. Kelley and Gregory A. CoxI I.
Add to Reading List

Document Date: 2013-03-31 21:25:33


Open Document

File Size: 2,32 MB

Share Result on Facebook

City

San Francisco / Rochester / /

Company

IgG / Johnson & Johnson / Amgen Inc. / Novartis / Eli Lilly and Company / Chiron Corp. / See Enzo Biochem Inc. / Lilly / B3b / Biogen Idec / ILEX/Schering AG / G.D. Searle & Co. / MedImmune / Merck / Chugai Pharm / Genentech Inc. / USPTO / Schering-Plough / Wyeth / Eli Lilly & Co. / /

Continent

America / /

Country

United States / /

Currency

USD / /

/

Event

Product Issues / /

IndustryTerm

patent law provisions / pharmaceutical product / written description law / therapeutic antibody products / heavy chain / particular antibody product / antibody technology / chemical structures / case law / prior applications / clear protocol / biopharmaceutical agent / antibody-like chemical / patent law / controversial patent law provisions / antibody products / light chain / mature technology / /

MedicalCondition

allergies / HIV / arthritis / macular degeneration / nephritis / HIV infections / multiple sclerosis / Human Diseases / psoriasis / lupus / infections / inflammatory diseases / additional validated disease / Immune-Mediated Diseases / sepsis / asthma / cancers / scleroderma / Alzheimer's disease / myocardial infarction / Autoimmune Disease / Diseases / Infection / fibrosis / /

Organization

Japan Patent Office / United States Court of Appeals / Enzo court / Univ. of Cal. / US Federal Reserve / European Patent Office / Univ. of Rochester / Noelle court / /

Person

Gregory A. Cox / James Darnell / Stephen G. Kunin / James J. Kelley / ALBERT L. LEHNINGER / /

Position

Patent Attorney / General / Associate General Patent Counsel / /

Product

Humira / Synagis / Herceptin / Zenapax / thyroglobulin / Simulect / Rituxan / Remicade / Bexxar / Mylotarg / ReoPro / Campath / Raptiva / Zevalin / Xolair / Tysabri / Guidelines / panel ' s reasoning / /

RadioStation

Biotechnology 51 AM / /

Technology

pharmacogenomic / Antibodies / Biotechnology / mature technology / pdf / clear protocol / Drug Discovery / antibody technology / CAT / /

URL

http /

SocialTag